No profile data available.
Decision Diagnostics Corp. (DECN) is an essential consumer products company in the medication retail outlets industry, based in Westlake Village, United States, with about 6 full-time employees.
It reported revenue of $1.98 million for fiscal year 2020, down 16.8% from fiscal year 2019, and net income of -$29.67 million. In Q3 2021 (the quarter ended September 30, 2021) revenue was $518,511, down 0.4% from a year before. Its market capitalization was $35,787 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2020; market data as of October 8, 2026.
Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services.
Decision Diagnostics reported $1.98 million in revenue for fiscal year 2020, down 16.8% from $2.38 million in fiscal year 2019. In Q3 2021 revenue was $518,511.
$35,787 as of October 8, 2026.
Listed companies of a similar size in the same industry (medication retail outlets) include Alternative Energy Partners, Inc. (AEGY), Oxford Investments Holdings Inc. (OXIHF), Omni Health, Inc. (OMHE), PeakBirch Commerce Inc. (PKBFF).